Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
July 20, 2020
|
| In: |
American journal of respiratory and critical care medicine
Year: 2020, Jahrgang: 202, Heft: 11, Pages: 1589-1592 |
| ISSN: | 1535-4970 |
| DOI: | 10.1164/rccm.202004-1200LE |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1164/rccm.202004-1200LE Verlag, lizenzpflichtig, Volltext: https://www.atsjournals.org/doi/10.1164/rccm.202004-1200LE 
|
| Verfasserangaben: | Simon Y. Graeber, Peter van Mourik, Annelotte M. Vonk, Evelien Kruisselbrink, Stephanie Hirtz, Cornelis K. van der Ent, Marcus A. Mall, and Jeffrey M. Beekman |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1745143890 | ||
| 003 | DE-627 | ||
| 005 | 20230426074240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210121s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1164/rccm.202004-1200LE |2 doi | |
| 035 | |a (DE-627)1745143890 | ||
| 035 | |a (DE-599)KXP1745143890 | ||
| 035 | |a (OCoLC)1341388931 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gräber, Simon Y. |d 1985- |e VerfasserIn |0 (DE-588)1056936177 |0 (DE-627)794247199 |0 (DE-576)412922029 |4 aut | |
| 245 | 1 | 0 | |a Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation |c Simon Y. Graeber, Peter van Mourik, Annelotte M. Vonk, Evelien Kruisselbrink, Stephanie Hirtz, Cornelis K. van der Ent, Marcus A. Mall, and Jeffrey M. Beekman |
| 246 | 3 | 3 | |a Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F five hundred eight del mutation |
| 264 | 1 | |c July 20, 2020 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.01.2021 | ||
| 700 | 1 | |a van Mourik, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vonk, Annelotte M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kruisselbrink, Evelien |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hirtz, Stephanie |e VerfasserIn |0 (DE-588)1067642781 |0 (DE-627)819049263 |0 (DE-576)426812832 |4 aut | |
| 700 | 1 | |a van der Ent, Cornelis K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mall, Marcus A. |d 1975- |e VerfasserIn |0 (DE-588)115507795 |0 (DE-627)691370532 |0 (DE-576)28992152X |4 aut | |
| 700 | 1 | |a Beekman, Jeffrey M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory and critical care medicine |d New York, NY : American Thoracic Society, 1959 |g 202(2020), 11, Seite 1589-1592 |h Online-Ressource |w (DE-627)26688492X |w (DE-600)1468352-0 |w (DE-576)075961563 |x 1535-4970 |7 nnas |a Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation |
| 773 | 1 | 8 | |g volume:202 |g year:2020 |g number:11 |g pages:1589-1592 |g extent:4 |a Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation |
| 856 | 4 | 0 | |u https://doi.org/10.1164/rccm.202004-1200LE |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.atsjournals.org/doi/10.1164/rccm.202004-1200LE |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210121 | ||
| 993 | |a Editorial | ||
| 994 | |a 2020 | ||
| 998 | |g 115507795 |a Mall, Marcus A. |m 115507795:Mall, Marcus A. |d 910000 |d 910500 |e 910000PM115507795 |e 910500PM115507795 |k 0/910000/ |k 1/910000/910500/ |p 7 | ||
| 998 | |g 1067642781 |a Hirtz, Stephanie |m 1067642781:Hirtz, Stephanie |d 50000 |e 50000PH1067642781 |k 0/50000/ |p 5 | ||
| 999 | |a KXP-PPN1745143890 |e 3840498015 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Simon Y. Graeber, Peter van Mourik, Annelotte M. Vonk, Evelien Kruisselbrink, Stephanie Hirtz, Cornelis K. van der Ent, Marcus A. Mall, and Jeffrey M. Beekman"]},"id":{"doi":["10.1164/rccm.202004-1200LE"],"eki":["1745143890"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"July 20, 2020"}],"relHost":[{"recId":"26688492X","corporate":[{"display":"American Thoracic Society","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"disp":"Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutationAmerican journal of respiratory and critical care medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.01.2022"],"titleAlt":[{"title":"AJRCCM online"},{"title":"AJRCCM"},{"title":"American review of respiratory diseases"}],"part":{"extent":"4","volume":"202","text":"202(2020), 11, Seite 1589-1592","issue":"11","pages":"1589-1592","year":"2020"},"pubHistory":["80.1959 -"],"title":[{"subtitle":"AJRCCM ; an official journal of the American Thoracic Society, Medical Section of the Lung Association","title":"American journal of respiratory and critical care medicine","title_sort":"American journal of respiratory and critical care medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1535-4970"],"zdb":["1468352-0"],"eki":["26688492X"]},"origin":[{"dateIssuedDisp":"1959-","publisher":"American Thoracic Society ; American Lung Association","dateIssuedKey":"1959","publisherPlace":"New York, NY ; New York, NY"}]}],"physDesc":[{"extent":"4 S."}],"person":[{"given":"Simon Y.","family":"Gräber","role":"aut","display":"Gräber, Simon Y.","roleDisplay":"VerfasserIn"},{"role":"aut","display":"van Mourik, Peter","roleDisplay":"VerfasserIn","given":"Peter","family":"van Mourik"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Vonk, Annelotte M.","given":"Annelotte M.","family":"Vonk"},{"family":"Kruisselbrink","given":"Evelien","display":"Kruisselbrink, Evelien","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Hirtz, Stephanie","roleDisplay":"VerfasserIn","role":"aut","family":"Hirtz","given":"Stephanie"},{"family":"van der Ent","given":"Cornelis K.","roleDisplay":"VerfasserIn","display":"van der Ent, Cornelis K.","role":"aut"},{"role":"aut","display":"Mall, Marcus A.","roleDisplay":"VerfasserIn","given":"Marcus A.","family":"Mall"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Beekman, Jeffrey M.","given":"Jeffrey M.","family":"Beekman"}],"title":[{"title":"Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation","title_sort":"Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation"}],"recId":"1745143890","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 21.01.2021"],"titleAlt":[{"title":"Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F five hundred eight del mutation"}]} | ||
| SRT | |a GRAEBERSIMCOMPARISON2020 | ||